Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen M Mowry

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
Neurology|February 24, 2017
PML in natalizumab-treated multiple sclerosis: Modeling errors and risk miscalculationsEllen M Mowry, Justin C McArthur
Current Neurology and Neuroscience Reports|October 29, 2025
Sensors in Multiple SclerosisAngeliki G Filippatou, Ellen M Mowry
Neurologic Clinics|November 22, 2017
The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to DiseaseEllen M Mowry, Justin D Glenn
Current Treatment Options in Neurology|March 18, 2018
The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a ReviewLeah J Mische, Ellen M Mowry
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 9, 2018
A review of vitamin D supplementation as disease-modifying therapyThomas Jack Shoemaker, Ellen M Mowry
Neurology(R) Neuroimmunology & Neuroinflammation|January 13, 2021
Obesity's role in MS: An intervention target with possible interactionsKathryn C Fitzgerald, Ellen M Mowry
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2020
Specific dietary interventions to tackle obesity should be a routine part of recommended MS care - CommentaryKathryn C Fitzgerald, Ellen M Mowry
The Lancet. Neurology|September 8, 2019
Another sphingosine 1-phosphate receptor modulator for the treatment of patients with multiple sclerosisEllen M Mowry, John R Corboy
Nature Reviews. Neurology|October 3, 2012
The influence of nutritional factors on the prognosis of multiple sclerosisGloria von Geldern, Ellen M Mowry
Multiple Sclerosis International|June 3, 2014
Outcome measures in multiple sclerosisRobert Bermel, Amy Waldman, Ellen M Mowry
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Neurology|February 24, 2017
PML in natalizumab-treated multiple sclerosis: Modeling errors and risk miscalculationsEllen M Mowry, Justin C McArthur
Current Neurology and Neuroscience Reports|October 29, 2025
Sensors in Multiple SclerosisAngeliki G Filippatou, Ellen M Mowry
Neurologic Clinics|November 22, 2017
The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to DiseaseEllen M Mowry, Justin D Glenn
Current Treatment Options in Neurology|March 18, 2018
The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a ReviewLeah J Mische, Ellen M Mowry
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 9, 2018
A review of vitamin D supplementation as disease-modifying therapyThomas Jack Shoemaker, Ellen M Mowry
Neurology(R) Neuroimmunology & Neuroinflammation|January 13, 2021
Obesity's role in MS: An intervention target with possible interactionsKathryn C Fitzgerald, Ellen M Mowry
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2020
Specific dietary interventions to tackle obesity should be a routine part of recommended MS care - CommentaryKathryn C Fitzgerald, Ellen M Mowry
The Lancet. Neurology|September 8, 2019
Another sphingosine 1-phosphate receptor modulator for the treatment of patients with multiple sclerosisEllen M Mowry, John R Corboy
Nature Reviews. Neurology|October 3, 2012
The influence of nutritional factors on the prognosis of multiple sclerosisGloria von Geldern, Ellen M Mowry
Multiple Sclerosis International|June 3, 2014
Outcome measures in multiple sclerosisRobert Bermel, Amy Waldman, Ellen M Mowry
Pageof 17